Sanofi’s Xenpozyme approved by European Commission - Drug Informics

Post Top Ad

Friday, 1 July 2022

Sanofi’s Xenpozyme approved by European Commission

Xenpozyme is a treatment for ASMD and the condition’s only current enzyme replacement therapy

from PharmaTimes: News RSS https://ift.tt/Ya7Ukyd

No comments:

Post a Comment

Post Top Ad